%0 Journal Article %T Quality Assurance in SPECT/CT for Radionuclide Therapy with Lutetium-177 %A Olivia Adu-Poku %A Eric Kotei Addison %A Bright Kwakye-Awuah %A Stephen Inkoom %A Francis Hasford %A Cletus Ahadzie %A Joseph Adom %A Isaac Kojo Wilson %J International Journal of Medical Physics,Clinical Engineering and Radiation Oncology %P 60-76 %@ 2168-5444 %D 2022 %I Scientific Research Publishing %R 10.4236/ijmpcero.2022.111006 %X This study was done to quality assure the Hawkeye SPECT/CT at the St. Olav¡¯s hospital and create a clinical method for doing individual dosimetry with 177Lu-octreotate in targeted radionuclide therapy for neuroendocrine tumors. Various quality control parameters were performed on Infinia Hawkeye SPECT/CT. A calibration dose of 160% ¡À 2% MBq was ordered and first calibrated for all the dose calibrators. The uniformity test was obtained using a 40 MBq Tc-99m point source positioned 2.5 m away from the two detectors. A 200 MBq Tc-99m was diluted in 70 ml of water, dispersed in six syringes for the registration test. A Lu-177 point source was placed in front of the detectors, one at a time, to check the energy peaks. The Jaczczak phantom with a hollow sphere set (volumes: 0.5, 1, 2, 4, 8, and 16) ml with an additional 60 ml sphere was used for the 3D sensitivity and recovery with Lu-177. Total activity of 945.3 MBq was added to 160 ml of water yielding an activity concentration of 5.908 MBq/ml in the spheres. The phantom was then scanned at various time intervals. A cylindrical phantom with a volume of 6283 ml was also used to obtain the cross-calibration measurement (cps/MBq). Total activity of 995.6 MBq was added and the phantom was scanned at days 0, 6, 13 and 23. The dose calibration factor was changed from 762 to 760 to achieve correct doses. The 2D mean sensitivity factor was 5.56 cps/MBq. Uniformities for %K Lutetium-177 %K Activity Concentration %K Dose Calibrator %K SPECT/CT %U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=115423